Moncton’s Soricimed Biopharma has raised a $200,000 follow-on investment from the New Brunswick Innovation Foundation as it continues research and development work on its treatment for pancreatic cancer.
NBIF previously invested $175,000 in Soricimed in 2020, and in a press release said the prospective drugmaker has raised a combined $26 million of equity and non-dilutive financing since it began..
Soricimed was founded in 2005 by Mount Allison professor Jack Stewart – now the Chairman and Chief Scientific Officer – after he discovered interesting medical properties in the saliva of the